EP 0178299 A4 19870428 - SUSTAINED RELEASE ORAL DOSAGE FORM FOR NAPROXYN.
Title (en)
SUSTAINED RELEASE ORAL DOSAGE FORM FOR NAPROXYN.
Title (de)
DOSIERUNGSFORM FÜR NAPROXYN FÜR DAUERVERABREICHUNG IM MUND.
Title (fr)
FORME DE DOSAGE ORALE A LIBERATION ENTRETENUE POUR NAPROXYN.
Publication
Application
Priority
US 8400431 W 19840321
Abstract (en)
[origin: WO8504099A1] Sustained release tablet and method for administration of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid over a prolonged period, a single administration of the sustained release tablet of the present invention providing a 24 hour administration of the drug. This oral sustained release dosage form is a tablet containing sufficient (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid to provide a sustained release over a prolonged period contained in granules formed into said tablet, said tablet consisting essentially of a plurality of compressed granules consisting essentially of from about 1 to about 30 parts by weight hydroxypropyl methylcellulose and about 1 to about 30 parts by weight polyvinylpyrrolidone and a lubricant for the granules, such as magnesium stearate. The oral sustained release dosage unit form permits a sustained release of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid over a period of about 24 hours, eliminating the need for dosing at different periods of the day.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 31/19 (2006.01)
CPC (source: EP)
A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 31/19 (2013.01)
Citation (search report)
- No relevant documents have been disclosed.
- See references of WO 8504099A1
Designated contracting state (EPC)
AT BE CH DE FR GB LI LU NL SE
DOCDB simple family (publication)
WO 8504099 A1 19850926; EP 0178299 A1 19860423; EP 0178299 A4 19870428
DOCDB simple family (application)
US 8400431 W 19840321; EP 84901535 A 19840321